1. Role of modelling and simulation in Phase I drug development;Aarons;Eur. J. Pharm. Sci.,2001
2. Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check;Yano;J. Pharmacokinet. Pharmacodyn.,2001
3. Food and Drug Administration, Guidance for Industry: Population Pharmacokinetics, FDA, Rockville, Maryland, USA, 1999.
4. Committee for Medicinal Products for Human Use, European Medicines Agency, Draft Guideline on Reporting the Results of Population Pharmacokinetic Analyses, EMEA, 2006.
5. Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004;Brendel;Clin. Pharmacokinet.,2007